MedTrace Logo

Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects

NCT02380248 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2018-07-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy and safety of Systane® Gel Drops in dry eye subjects following 90 days of QID (4 times/day) dosing.

Conditions

  • Dry Eye

Interventions

OTHER

Polyethylene Glycol, 0.4%, Propylene Glycol, 0.3% eye drops

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Head, CTM, Med Affairs · Alcon Laboratories Pvt Ltd (India)

  • Sr. Clinical Manager, Global Trial Leadership · Alcon, A Novartis Division

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-14
Primary Completion
2016-06-01
Completion
2016-06-01

Countries

  • India

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02380248 on ClinicalTrials.gov